[Recent advances and pharmacological basis of the medical treatment of Parkinson's syndrome].
D000547:Amantadine / Q000494:pharmacology / Q000627:therapeutic use; D002395:Catecholamines / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007099:Imipramine / Q000494:pharmacology / Q000627:therapeutic use; D010276:Parasympatholytics / Q000494:pharmacology / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D014364:Tryptophan / Q000378:metabolism
D002395:Catecholamines; D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D004295:Dihydroxyphenylalanine; D014364:Tryptophan; D000547:Amantadine; D007099:Imipramine